Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
about
3-nitrotyrosine modified proteins in atherosclerosisThe roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study.Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina.A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.Effect of Hemodialysis on Plasma Myeloperoxidase Activity in End Stage Renal Disease Patients.Association of Plasma Myeloperoxidase Level with Risk of Coronary Artery Disease in Patients with Type 2 DiabetesRelationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetesUsefulness of Relative Hypochromia in Risk Stratification for Nonanemic Patients With Chronic Heart FailureUsefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortiaCurrent role of myeloperoxidase in routine clinical practice.Critical appraisal of inflammatory markers in cardiovascular risk stratification.Novel biomarkers for cardiovascular risk assessment: current status and future directions.Identifying new Risk Markers and Potential Targets: The Value of the Proteome.Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.The effect of N-acetylcysteine on oxidative serum biomarkers of hemodialysis patients.Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease.Evaluation of the cardiovascular effects of varenicline in rats.Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome.Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study.Chlorination and oxidation of human plasma fibronectin by myeloperoxidase-derived oxidants, and its consequences for smooth muscle cell function
P2860
Q28083260-5F98A64D-BC16-423A-9560-376A3896FB50Q30240734-639E19B8-8B75-4370-8BAD-4CD2B9E1D51AQ33709886-7BE26698-8733-4A68-A08A-C76E9D70D36AQ34072878-78026A95-596A-42DA-B377-A700179B4BE4Q35026376-64866CFE-80D7-47D6-9084-AB141B5C27FCQ35683327-5082C11B-D725-43A8-B635-2D72E084CCDEQ36079999-835A9D73-788C-4303-9CB7-C68335B79771Q36106145-1A7D80BB-3AA1-4353-9672-DBF23772F26EQ36417045-AE24CA86-FFD8-4B50-BBA9-B2D2CB5B2438Q36739557-10877A88-BC7C-445D-8E17-5748924BDB0AQ36810879-B8C5ADE2-0017-406F-99C0-A3292682A3E6Q37045120-1BDC0C36-76DC-43C1-ADE9-DEB821E8C36DQ37859787-DE8BA33D-667A-48FF-9B83-1FA92482BFF3Q38219501-1DC10E58-1415-4DFD-8413-694C71723B6CQ38613760-BC2894BD-154C-4AA0-BBF6-406125675842Q38756916-D233D3D7-C9EB-4E18-A1DB-859171AB2694Q41914520-BD045F23-635E-4CEB-8CA4-F68A4B38E143Q42427842-65C0883F-B39F-4BE1-B319-4C6BA738DE44Q42973489-389E1763-DE02-4B8E-819E-AF737FF05461Q43200073-D8E73563-AD20-4EED-A488-1F355471DE6BQ46165199-DC4C88D5-C281-409F-9DAB-98FB1D76B84EQ48033119-96D66242-BE15-4104-B7AF-3073BF8ACD3BQ55416022-BA3C46D4-A854-44E1-8B1F-7CC3A178EF19Q58762763-77AEFB22-5B43-4B2A-B35B-C1C4B85C7D26
P2860
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@ast
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@en
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@nl
type
label
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@ast
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@en
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@nl
prefLabel
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@ast
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@en
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@nl
P2093
P2860
P1433
P1476
Plasma myeloperoxidase predict ...... t for coronary artery disease.
@en
P2093
Stanley L Hazen
Stephen J Nicholls
W H Wilson Tang
P2860
P356
10.1373/CLINCHEM.2010.152827
P407
P577
2010-11-08T00:00:00Z